Auto Amazon Links: No products found.
An expansion in the role of pharmacists across England is set to improve patient care by enabling them to prescribe a wider range of medications. This initiative aims to reduce the strain on general practitioner (GP) services and hospitals by allowing pharmacists to take on more responsibility in managing common health conditions. Currently, under the Pharmacy First scheme, pharmacists can prescribe treatments for ailments such as sore throats, earaches, sinus infections, shingles, impetigo, infected bites, and urinary tract infections.
The scheme, which began in 2024, enables patients to seek advice and treatment directly from their local pharmacist. Services include access to over-the-counter remedies, prescription medicines, and care related to eye, ear, oral, dental, and digestive issues. Since its inception, the scheme has facilitated over 3.3 million consultations from March 2025 to February 2026, according to the Department of Health and Social Care.
Starting this autumn, the government is investing £340 million to extend the list of ailments pharmacists can treat by adding five additional common conditions. Although the exact illnesses to be included have not yet been disclosed, this funding underscores a commitment to harness pharmacists’ expertise and improve local healthcare access. Health Minister Stephen Kinnock emphasized the benefits, stating the expansion will “make the most of our highly skilled pharmacists, while boosting access to services and giving patients more care right on their doorstep.” He also highlighted independent prescribing as a key element in reducing pressure on GPs and simplifying patient care pathways.
Despite the government’s enthusiasm, pharmacy representatives have raised concerns about the scheme’s financial support. The National Pharmacy Association (NPA) acknowledged the expansion as a positive move but criticized the deal for failing to tackle increasing business rates, employment expenses, and medication costs. Dr Olivier Picard, NPA chairman, expressed worries that the current funding level is insufficient: “We remain concerned that it does very little to close the £2.5bn funding gap that the NHS itself identified a year ago.” He cautioned that many pharmacies might struggle to adopt the new responsibilities without adequate resources. Similarly, Dr Leyla Hannbeck, Chief Executive of the Independent Pharmacies Association, noted the funding does not align with the workload demands. She warned on BBC Radio 4’s Today programme that numerous pharmacists could face significant financial difficulties maintaining their operations amid these changes
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.